Delivery Order SPE2DB22D1106-SPE2DB25FFAP1
- Not listed
- The Defense Logistics Agency awarded a $3,110.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment. This firm fixed price delivery order, valued at $2,475.20, represents a non-set-aside competitive award and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,174.20 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 18, 2025, with a completion date of July 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order falls...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment in 3.5-gram units, with a contract value of $1,362.97 and an ultimate completion date of July 30, 2025. This non-set-aside award reflects a competitive procurement process and represents a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for erythromycin ophthalmic with a ceiling value of $3,098.76. The contract, awarded on November 25, 2024, with an ultimate completion date of November 26, 2024, represents a non-competitive, non-set-aside procurement executed as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5GM units, with a ceiling value of $1,075.00. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the contractor's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,902.85 delivery order to AmerisourceBergen Drug Corp on December 22, 2023, for the supply of Erythromycin Ophthalmic. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work is to be performed at the contractor's corporate office location...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This competitive, non-set-aside contract has a ceiling value of $2,675.15 and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,207.94 to AmerisourceBergen Drug Corp for the supply of erythromycin ophthalmic medication. This competitively awarded, non-set-aside contract was issued on December 22, 2023, with an ultimate completion date of December 26, 2023. The place of performance is listed as the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract employs firm fixed-price pricing and is structured as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAP1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,301.90 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment. The contract is firm fixed price with no set-aside designation and an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical supplies and medications to federal healthcare systems, particularly military and veteran programs. The underlying IDC serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals, specialty medications, vaccines, and medical devices across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for erythromycin eye ointment exemplifies the company's role in fulfilling routine medical procurement needs through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/30/25 |